Neurology Updates
All the atest articles, research and news from worlds leading Neurology Journals. Discussion group https://t.me/Professional_Medical_Discussion
Show moreš Analytical overview of Telegram channel Neurology Updates
Channel Neurology Updates (@neurology_updates) in the English language segment is an active participant. Currently, the community unites 16 175 subscribers, ranking 1 504 in the Medicine category and 2 332 in the USA region.
š Audience metrics and dynamics
Since its creation on Š½ŠµŠ²ŃŠ“омо, the project has demonstrated rapid growth, gathering an audience of 16 175 subscribers.
According to the latest data from 05 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 311 over the last 30 days and by 5 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 6.93%. Within the first 24 hours after publication, content typically collects 2.64% reactions from the total number of subscribers.
- Post reach: On average, each post receives 1 121 views. Within the first day, a publication typically gains 427 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 1.
- Thematic interests: Content is focused on key topics such as disease, stroke, alzheimer, cell, dementia.
š Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
āAll the atest articles, research and news from worlds leading Neurology Journals.
Discussion group
https://t.me/Professional_Medical_Discussionā
Thanks to the high frequency of updates (latest data received on 06 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Data loading in progress...
| Date | Subscriber Growth | Mentions | Channels | |
| 05 September | +9 | |||
| 04 September | +13 | |||
| 03 September | +7 | |||
| 02 September | +5 | |||
| 01 September | 0 |
| 2 | Neural geometry guides learning
https://www.nature.com/articles/s41593-026-02442-6 | 440 |
| 3 | Structured experience shapes strategy learning and neural dynamics in the medial entorhinal cortex
https://www.nature.com/articles/s41593-026-02409-7 | 598 |
| 4 | Priming of CD8<sup>+</sup> T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration
https://www.nature.com/articles/s41593-026-02427-5 | 552 |
| 5 | Mitochondrial calcium influx-driven bioenergetics selectively enable drug addiction
https://www.nature.com/articles/s41593-026-02421-x | 631 |
| 6 | Glutamate concentration tunes AMPA receptor function through conductance-state occupancy
https://www.nature.com/articles/s41593-026-02414-w | 584 |
| 7 | [Articles] Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00276-0/fulltext?rss=yes | 703 |
| 8 | [Comment] Finding more intracranial aneurysms that will never rupture
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00315-7/fulltext?rss=yes | 666 |
| 9 | Whole-exome sequencing in individuals with obsessiveācompulsive disorder and chronic tic disorders identifies 36 large-effect risk genes
https://www.nature.com/articles/s41593-026-02419-5 | 724 |
| 10 | State-dependent signal flow hierarchy in the human cerebral cortex
https://www.nature.com/articles/s41593-026-02389-8 | 674 |
| 11 | ATTs in Patients With Non-AD Copathologies
https://jamanetwork.com/journals/jamaneurology/fullarticle/2853597 | 739 |
| 12 | Tirofiban for Branch Atheromatous DiseaseāRelated Stroke
https://jamanetwork.com/journals/jamaneurology/fullarticle/2853598 | 681 |
| 13 | Treatment Discontinuation in MOGADāOne Size Does Not Fit AllāReply
https://jamanetwork.com/journals/jamaneurology/fullarticle/2853599 | 610 |
| 14 | Treatment Discontinuation in MOGADāOne Size Does Not Fit All
https://jamanetwork.com/journals/jamaneurology/fullarticle/2853600 | 693 |
| 15 | Tirofiban for Branch Atheromatous Disease
https://jamanetwork.com/journals/jamaneurology/fullarticle/2853601 | 730 |
| 16 | Spatial mapping of RNA turnover kinetics in the mouse brain
https://www.nature.com/articles/s41593-026-02420-y | 845 |
| 17 | https://www.instagram.com/updates_in_medicine?igsi=eWJ2N3p2MmxvNXJ0&utm_source=qr | 587 |
| 18 | Social isolation recruits amygdalaāmedial prefrontal cortex projections to escalate alcohol drinking in male mice
https://www.nature.com/articles/s41593-026-02413-x | 1 524 |
| 19 | [Articles] Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00278-4/fulltext?rss=yes | 1 370 |
| 20 | [Comment] Targeting orexin signalling in narcolepsy
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00316-9/fulltext?rss=yes | 1 127 |
